Print
Email
Print Edition StoriesThursday, July 16, 2009
Biogen Idec co-founder Sharp retires from board
By Mass High Tech staff
MHT's Galen Moore: Hiring trends and opportunities
MHT managing editor Rodney Brown on NECN: 22 tech companies give back to community
Flash Slideshow: Mass High Tech All-Stars Thought Leadership Roundtable
Biogen Idec Inc. co-founder Phillip Sharp has announced plans to retire from the company’s board of directors, a role he’s held since 1982.
Sharp won the Nobel Prize for Medicine in 1993 for discovering split genes, and in 2006, he was awarded a National Medal of Science. Sharp currently serves as Institute Professor at MIT in the biology department and the Center for Cancer Research. He has worked as director of the Center for Cancer Research from 1985 to 1991, as head of the Department of Biology from 1991 to 1999, and as director of the McGovern Institute for Brain Research at MIT from 2000 to 2004.
Biogen NV was founded in 1978 after several biologists worldwide met in Geneva, Switzerland, and decided to form a new pharmaceutical firm, according to the Biogen Idec web site. Five years later, in 1983, Biogen held its initial public offering.
Biogen Idec (Nasdaq: BIIB) produces drugs for patients in more than 90 countries. Its drugs treat diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
